ArticleCell death & disease2019

Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3.

Rong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.